Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Milad Nazarzadeh


  • PI Group: Dr Kazem Rahimi

Milad Nazarzadeh is a third year DPhil student at the University of Oxford with a scholarship from the British Heart Foundation. His project focuses on the effect of blood pressure-lowering drugs and drug-drug interactions on the risk of type 2 diabetes through integrating epidemiologic and genetic data, supervised by Prof Kazem Rahimi, Dr Dexter Canoy, Dr Abbas Dehghan, Dr Derrick Bennett and Prof George Davey Smith.

Milad completed his BSc of Public Health at the Zanjan University of Medical Sciences, Iran, then received his MSc of Epidemiology from Shahid Beheshti University of Medical Science, Tehran, Iran. He was faculty member, lecturer and research director at University of Medical Sciences, Iran (Sabzevar and Torbat Heydarieh, 2015- 2017). Then, he joined The George Institute for Global Health, UK at the University of Oxford as Epidemiologist (2017-2019). Also, he is currently Associate Editor of the BMC Cardiovascular Disorders. His research interests include blood pressure, cardiovascular disease and Pharmacogenetics, using methodologies such as systematic review and meta-analysis, advanced statistical modelling, individual-patient meta-analysis and Mendelian Randomisation.

Social media

Recent publications

More publications